ArticleEuropean journal of medical research2025
REG4 induces angiogenesis in ulcerative colitis by upregulating MMP-7 expression and downregulating sVEGFR1 level.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAngiogenesis is suggested as pathogenesis of inflammatory bowel disease (IBD). However, how angiogenesis mediates pathogenesis of ulcerative colitis (UC), a common form of IBD, remains elusive.
methodsDextran sulfate sodium salt (DSS)-induced UC mouse models were established. Then, these mice were injected with short hairpin RNA against regenerating family member4 (shREG4), followed by evaluation of weight and disease activity index (DAI). Collected colon tissues underwent hematoxylin and eosin staining and immunohistochemistry to detect morphological changes and microvascular density (MVD). Inflammation cytokines, soluble vascular endothelial growth factor receptor1 (sVEGFR1) and VEGF levels were measured using enzyme-linked immunosorbent (ELISA) assay. Matrix metallopeptidase7 (MMP-7) was measured using western blot. REG4 overexpression plasmid-transfected NCM460 cells experienced quantitative real-time reverse transcription polymerase chain reaction and western blot. Human intestinal microvascular endothelial cells (HIMECs) were co-cultured with NCM460 cells that had been transfected with REG overexpression plasmid and treated with MMP-7 mAb and/or sVEGFR1. MMP-7 or sVEGFR1 levels in both culture medium were tested using ELISA. HIMECs angiogenesis was measured by Angiogenesis kit.
resultsIn vivo, DSS-induced mice exhibited lower weight and higher DAI. Collected mice colon tissues showed enhanced inflammation, morphological changes, MVD, and expressions of VEGF, REG4 and MMP-7, which were all reversed after DSS-induced mice injected with shREG4. In vitro, REG4 overexpression-transfected NCM460 cells and its culture medium presented higher MMP-7 level. After co-culture with REG4 overexpression-transfected NCM460 cells, HIMECs culture medium demonstrated lower level of sVEGFR1 and higher angiogenesis, and the latter was reversed by MMP-7 mAb and/or sVEGFR1 treatment in NCM460 cells.
conclusionREG4 induces angiogenesis in UC by upregulating MMP-7 and downregulating VEGFR1.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.